Article Text

Download PDFPDF
Can serum amyloid A concentrations aid diagnosis of synovial sepsis?
  1. Thais Ribera Townsend, DVM, PhD1
  1. 1Hospital de Referencia La Equina, Camino de Martagina, Km.1 29692 Sabinillas, Manilva, Málaga Spain
  1. E-mail for correspondence: thais{at}

Statistics from

As equine practitioners, we all know that diagnosing synovial sepsis can sometimes be challenging when trying to distinguish between early stage infective arthritis, with a relatively low total nucleated cell count (TNCC), and traumatic arthritis with a high white blood cell count.1 Another challenge can be obtaining enough synovial fluid, if any, to allow determination of the three most useful parameters in making the diagnosis of septic synovitis: TNCC, neutrophil percentage and total protein.

Under the worst circumstances, if a very chronic septic process is encountered with extensive soft tissue trauma or infection and large wounds, synovial cavity puncture, aspiration and withdrawal may not be possible or should even be discouraged (Fig 1). In these particular circumstances, a systemic quick, affordable sensitive and specific synovial biomarker test to aid the immediate diagnosis is needed to allow clinical therapeutic decisions to be made rapidly.


Extensive distal left hindlimb celullitis secondary to a chronic wound involving the digital flexor tendon sheath

In a study by Robinson and others,2 summarised on p 425 of this week’s Veterinary Record, serum amyloid A (SAA) seems to have been identified as an ideal biomarker, supported by evidence from a large number of clinical cases that blood and synovial fluid SAA concentrations can both be used to differentiate between septic or contaminated versus …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.